. In addition, the prognosis of cardiovascular disease has improved because of better medical care, including diagnosis, treatment of acute events, and care after hospital stay 5, 6 . Despite this progress, coronary heart disease and stroke remain the two leading causes of disease burden globally 4 . From 2006 to 2016, the number of people dying from cardiovascular disease actually increased by 15%, reaching 17.6 million deaths per year, because of population ageing and growth 4 . The number of years lost owing to ill health, disability, or early death from cardio vascular disease is 18 times higher than the number of cardiovascular deaths, at 321.9 million per year 7 . These rates underline the continuing need to identify new complementary targets for prevention and to evaluate the future potential of therapeutic management of patients.
One emerging risk and prognostic factor for cardiovascular disease is stress, the topic of this Review. A large body of prospective research links stress to increased rates of coronary heart disease, stroke, and other presentations of cardiovascular disease, such as atrial fibrillation. In addition, analyses of prospective follow-up data from 27,461-603,838 adults confirm outcome specificity, supporting the associations of stress with cardiovascular disease [8] [9] [10] [11] , diabetes mellitus [12] [13] [14] , and mental health 15 , but not with cancer (all sites or lung, prostate, breast, colon, or rectum cancer) 16, 17 or with diseases in the gastrointestinal 18 and respiratory systems Abstract | Cardiovascular disease remains the leading cause of disease burden globally, which underlies the continuing need to identify new complementary targets for prevention. Over the past 5-10 years, the pooling of multiple data sets into 'mega-studies' has accelerated progress in research on stress as a risk and prognostic factor for cardiovascular disease. Severe stressful experiences in childhood, such as physical abuse and household substance abuse, can damage health and increase the risk of multiple chronic conditions in adulthood. Compared with childhood stress and adulthood classic risk factors, such as smoking, high blood pressure, and high serum cholesterol levels, the harmful effects of stress in adulthood are generally less marked. However, adulthood stress has an important role as a disease trigger in individuals who already have a high atherosclerotic plaque burden, and as a determinant of prognosis and outcome in those with pre-existing cardiovascular or cerebrovascular disease. In real-life settings, mechanistic studies have corroborated earlier laboratory-based observations on stress-related pathophysiological changes that underlie triggering, such as lowered arrhythmic threshold and increased sympathetic activation with related increases in blood pressure, as well as pro-inflammatory and procoagulant responses. In some clinical guidelines, stress is already acknowledged as a target for prevention for people at high overall risk of cardiovascular disease or with established cardiovascular disease. However, few scalable, evidence-based interventions are currently available.
In this Review, we assess the current evidence for stress as a risk factor for cardiovascular disease. Our main focus is on reproducible findings obtained from the largest stress studies to date and the most recent literature-based and individual-participant data meta-analyses. Rather than just updating previous field synopses [21] [22] [23] [24] [25] [26] , we seek to determine the clinical and public health importance of major stressors in relation to various presentations of cardio vascular disease and to provide comparisons to more established risk factors and treatments, such as smoking, physical activity, and statin therapy. To cover the multiple roles of stress in cardiovascular pathology, this Review is organized according to the disease process, from the long-term development of atherosclerosis to subclinical disease, and the acute triggering of cardiac or cerebro vascular events in people with advanced underlying disease. In addition to this aetiological process, stress is thought to impair recovery, accelerate the progression of the disease, and contribute to cardiovascular death among patients who have survived an acute coronary syndrome or stroke; in other words, stress might act as a prognostic factor. We conclude this Review with a discussion of the implications of managing stress for cardiovascular disease prevention and treatment.
Measurement of stress
The most commonly studied adult stressors include stress at work and social isolation 22 , although other stressors, such as marital problems, caring for a sick spouse or child at home, and the death of a close person, have also been linked to increased risk of cardiovascular disease [27] [28] [29] . Other stressors include natural and man-made disasters (for example, earthquakes, terrorist attacks, and wars) that elicit clinical events and cardiac abnormalities 30, 31 . Commonly studied episodic stressors include emotional upset, sporting events, and stressful changes at work, such as layoffs 32, 33 . In this Review, we discuss evidence on all these stressors and also on overall perceived stress, because previous reviews have discussed depression 34−36 , anxiety 37 , common mental disorder and/or psychological distress 38 , vital exhaustion 39 , and post-traumatic stress disorder (PTSD) 40 , which, despite being correlates of stress, are consequences rather than sources of stress. Various personality types or personality characteristics have been considered as risk factors for experiencing both stress and cardiovascular disease. These person ality factors have been addressed in previous publications, and include the type A behaviour pattern 41 and type D personality 42 , as well as anger-proneness and hostility 43 . At least three distinct approaches are available to measure stress: self-report (perception), external observation, and biomarkers
. Although self-completion questionnaires and interviews are still the most commonly used methods, new technology is increasingly providing opportunities to make progress in stress measurement. Mobile health (mHealth) applications on mobile telephones and wearable devices for interactive communication allow more precise monitoring of specific stress exposures and their timing in relation to physiological changes 44 . For example, PTSD Coach is a smartphone application designed to help individuals who have PTSD measure and self-manage their symptoms 45 . The use of biomarkers includes measuring stress on a moment-to-moment basis (for example, via salivary corti sol) and summary measures over longer time spans (for example, 3-month cortisol assay by hair sample analysis). A wide range of mobile, even wearable electrochemical sensors and biosensors has been developed for real-time, noninvasive monitoring of electrolytes and metabolites in sweat or saliva as indicators of a wearer's biological status 44 . For example, surface-enhanced Raman spectro scopy biosensor assays have been developed to detect cortisol levels in saliva 46 , and stored electrocardiograms (ECGs) from implantable cardioverter-defibrillators can be used as real-time data to investigate associations of stress with arrhythmia 47 .
Scale of the problem Pooling of multiple, individual-level prospective data sets into mega-studies involving hundreds of thousands of participants has accelerated the progress of research on stress and cardiovascular disease, corresponding to developments in genetic approaches and study of classic cardiovascular risk factors. For stress research, these mega-studies are a fairly recent paradigm shift, as major multicohort consortia, such as the IPD-Work consortium, were established <10 years ago 48, 49 . Combining data across studies has several advantages. Pooled data increase the precision (but not necessarily the accuracy) of effect estimates and the power to detect weak signals between the risk factor and the disease. Further advantages include the possibility of testing the robustness of associations across subgroups to examine whether the observed relation ship is a result of a third factor (confounder). In addition, convincingly showing and publishing the absence of associations is possible with large data sets.
Risk factors doubling the likelihood of developing a disease are considered to have a large effect size 50 . For example, meta-analyses have reported a hazard ratio of ≥2 for the associations of classic risk factors, such as
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• Pooling of individual-level data and published data from multiple cohorts into mega-studies has allowed for a more precise assessment of the association between stress and cardiovascular disease • In the general population, adults with work stress or private-life stress have a 1.1-fold to 1.6-fold increased risk of incident coronary heart disease and stroke • The excess risk of cardiovascular disease associated with adulthood stress is less marked than the risks associated with smoking, high blood pressure, high serum cholesterol levels, obesity, or multiple severe stressful experiences in childhood • Stress in adulthood has an important role as a disease trigger in individuals with high atherosclerotic plaque burden and as a determinant of prognosis and outcomes in those with pre-existing cardiovascular or cerebrovascular disease • Potential pathophysiological effects of stress involve increased cardiac electrical instability, myocardial ischaemia, plaque disruption, and thrombus formation, contributing to clinical events such as arrhythmia, myocardial infarction, cardiomyopathy, and stroke • Only European guidelines for cardiovascular disease prevention acknowledge stress as a clinically meaningful risk factor in individuals with a high overall risk of cardiovascular disease or with established cardiovascular disease diabetes and midlife high blood-pressure levels, with coronary heart disease and ischaemic stroke 51, 52 . Metaanalyses have also demonstrated a strong association between high serum cholesterol levels before the age of 50 years and vascular-related death 53 . Severe obesity (BMI >35 kg/m 2 ) doubles the risk of cardiovascular disease and increases the risk of comorbid cardiovascular disease and diabetes more than 10-fold 54 . The rates of myocardial infarction in smokers are more than two times those in non-smokers 55 . FIGURE 1 summarizes evidence on stress as a predictor of cardiovascular disease and death from meta-analyses of published papers and from pooled analyses of individual-participant data from multiple cohort studies. Whereas the exposure and outcome definitions were hetero geneous in published studies, many individualparticipant data analyses used predefined and harmonised exposures, an approach that reduces bias owing to multiple testing 48, 49 . The findings from the two types of multi cohort studies are consistent in showing that compared with classic risk factors (high blood pressure, high serum cholesterol levels, obesity, diabetes, and smoking), the hazard ratios of incident coronary heart disease and ischaemic stroke for stress are less marked in the general population [8] [9] [10] [11] 56, 57 . The only exception is the excess risk associated with a history of multiple severe stress experiences in childhood, such as physical abuse and household substance abuse 58 . This association might be indirect, because individuals who have had such experiences are more than twice as likely to be smokers in adulthood and almost six times as likely to drink problem atically compared with those who did not have severe stress experiences in childhood 58 . In contrast to the moderate associations of adulthood stress with cardiovascular and cerebrovascular events in the general population, strong associations between stressors and cardiovascular disease have been observed in high-risk populations 29, 32, 59, 60 . In combination, these observations suggest that stress in adulthood has a more pronounced role as a trigger of cardiovascular disease than as a contributor to the development of the disease (FIG. 1) . In patients with cardiovascular disease, several stressors have also been strongly correlated to cardio vascular end points, such as recurrent cardiovascular events and mortality [61] [62] [63] [64] [65] . This observation indicates that stress in adulthood might also have a more important role in the progression and outcome of cardiovascular disease than as a contributor of the development of the disease.
In general, strong multivariable-adjusted associations are less likely to be confounded than weak multivariable-adjusted associations. For example, the 4.7-fold excess risk of a cardiac event during an anger outburst in individuals at high risk of cardiovascular disease 60 could be explained away only if an unmeasured confounder was associated with both stress and cardiac events with a hazard ratio as large as 9.0; a weaker uncontrolled confounder could not account for the association (FIG. 2) . By contrast, an unmeasured confounder that doubled the likelihood of both work stress and stroke could explain the entire 1.3-fold increased risk of stroke among individuals working long hours 10 .
Stress mechanisms and pathophysiology
The acute stress response, an integrated cascade of physio logical reactions in the face of challenging situations, has been well described 21, 26 . Much less is known about how stress responses convert to pathological changes over time, contributing to the development and progression of cardiovascular disease. Similarly, whereas the evidence quantifying links between various stressors and disease end points is rapidly accumulating (FIG. 1) , less progress has been made in understanding which speci fic pathophysiological changes underlie these links. In the following section, we describe the main features of the acute stress response and review the evidence on stress-related pathophysiological changes, related both to atherosclerosis and to the triggering of major cardiovascular events (FIG. 3) .
Acute stress response Activation of the stress response produces changes in brain stress-responsive neurocircuitry, affecting vigilance to sensory stimuli, producing emotional responses of fear and avoidance, and stimulating peripheral physio logical responses 21 . Peripheral physiological responses include the autonomic nervous system response, hypothalamuspituitary-adrenal (HPA) responses, and elevation of the levels of inflammatory proteins in the absence of pathogens (known as sterile inflammation) 23, 66 .
Autonomic nervous system response. Briefly, the autonomic nervous system, which innervates nearly all organs of the body, activates within seconds after exposure to a stressor, inducing both sympathetic and parasympathetic nervous system responses. The catecho lamines adrenaline (released by the adrenal medulla) and noradrenaline (released by the sympa thetic nerve terminals) increase the heart rate and decrease heart rate variability, optimize blood flow to muscle tissues, and elevate core body temperature 67 . The sympathetic nervous system has direct cardiostimulatory effects (chronotropy and inotropy via β 1 -adrenergic receptors) and pressor effects (via α 1 -adrenergic receptors) and also affects metabolism (promotes insulin resistance and lipolysis) and the immune system 68, 69 , including inhibition of mast-cell degranulation by stimu lation of IL-6 release (a pro-inflammatory cytokine). The parasympathetic nervous system releases acetylcholine to inhibit sympathetic nervous system drive to the tissues. However, the stress-related regulatory process is often characterized by removal of sympathetic inhibition to enhance excitation. For example, the stress response can involve initial simultaneous activation of both the sympathetic and parasympathetic systems, followed by parasympathetic nervous system withdrawal to sustain stress-evoked elevated heart rate 70 .
Hypothalamus-pituitary-adrenal responses. The HPA axis activates within minutes of exposure to a stressor. The hypothalamus releases corticotropin-releasing hormone in the anterior pituitary 67 . Corticotropin-releasing hormone stimulates the release of adrenocorticotropic hormone into the blood circulation, which in turn stimu lates the adrenal cortex to release the gluco corti coid cortisol, producing increases in blood glucose levels 71 . When the circulating glucose level is high, β-cells in the pancreas release insulin, which promotes the absorption of glucose from the blood into fat tissues, the liver, and skeletal muscle cells. In combination, the autonomic nervous system and HPA-axis response affect haemostatic factors, increasing platelet activation, fibrinogen levels, viscosity, and coagulation factors.
Inflammatory response. Activation of the stress system, especially after severe stressors, with the ensuing increase in circulating catecholamines can stimulate exosomal damage and the release of danger-associated molecular patterns (DAMPs) 66 , which are endogenous molecules that can stimulate an inflammatory response. The stress response might also reduce the exosomal cargo of immunoinhibitory microRNAs, a further factor contributing to stress-related sterile inflammation 66 . One of the puzzles of the stress response is the simultaneous increase in inflammation and gluco corticoid levels, such as cortisol, given that steroid hormones are anti-inflammatory. One explanation is that chronic or repeated exposure to a stressor leads to exhaustion of
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a General population (aetiology) the stress response, contributing to chronic low-grade inflammation and antigen-specific immunosuppression 66 . Furthermore, cortisol might only limit inflammatory responses, and the pro-inflammatory cytokine expression induced by stress would be much greater in the absence of increased cortisol 72 . In addition, glucocorticoids can have pro-inflammatory effects under some circumstances. In vitro administration of glucocorticoids induces an increase in cytokine production and the activ ation of nuclear factor-κB (NF-κB) in isolated macro phages 73 , and pretreatment of healthy individuals with cortisol enhances the production of IL-6 in response to a subsequent endotoxin challenge 74 . Glucocorticoid responses to stress have been proposed to be neuro endocrine warning signals to the innate immune system, sensitizing neuro inflammatory processes even after the corticosteroid response has dissipated 75 .
Pathophysiological changes
Stress-related changes in the sympathetic-parasympathetic balance and the tone of the HPA axis might adversely affect the cardiovascular system both by acceler ating the atherosclerotic process and by precipitating the occurrence of a cardiovascular or cerebrovascular event 26 . Whereas the pathophysiological effects on the progression of atherosclerosis are likely to involve repeated or chronic exposure to stress, stress-related trigger ing of events among people with an already high atherosclerotic plaque burden might also be a consequence of acute stress responses.
Atherosclerosis and metabolic dysregulation. In the general population, combined long-term effects of dysfunction of both the autonomic nervous system and HPA-axis can, in principle, contribute to changes that accelerate atherosclerosis, such as increases in blood-pressure levels and imbalance between vasodilatating and vasoconstricting substances produced by, or acting on, the endothelium 21 . However, no consistent evidence demonstrates an association of stress with major atherosclerosis risk factors such as hypertension and LDL-cholesterol levels [76] [77] [78] [79] [80] (TABLE 1) . By contrast, stress has been linked to an increased risk of developing diabetes 14 , a major risk factor for coronary heart disease, ischaemic stroke, and haemorrhagic stroke 51 (TABLE 1) .
This association was observed both among individuals with a healthy lifestyle and those with unhealthy lifestyle factors 12, 14 . The mechanisms underlying the increased risk of developing cardiovascular disease among individuals with stress can also be indirect via lifestyle changes that accelerate atherosclerosis and metabolic dysregulation. For example, a marginal increase in smoking frequency has been observed in smokers under stress 81 , and meta-analyses show that individuals with extensive working hours are more likely to increase their alcohol use to levels that pose a health risk 82 . Evidence also suggests that work-related stress is associated with reduced leisure-time physical activity 83 . In the British Whitehall II study 84 , participants with long-term stress were more likely to have an unhealthy diet than those participants free of stress. Furthermore, at least two meta-analyses, one based on published studies 85 and another combining published and unpublished individual-level data 86 , confirmed an association between stress and obesity. However, the association of stress with weight change seems to be complex as some individuals tend to lose weight under stress, others gain weight, and others experience no changes 87 .
Triggering of cardiovascular or cerebrovascular events.
The potential of psychological stress to trigger myocardial ischaemia in people with underlying coronary arterial disease was recognized several hundred years ago 88 . The first detailed description of angina pectoris in the medical literature in 1772 noted that angina pectoris "is increased by disturbance of the mind" (REF. 89 ). Numerous independent studies have subsequently confirmed this statement in experimental and real-life settings [90] [91] [92] [93] [94] [95] [96] . Among individuals who already have a high atherosclerotic plaque burden, multiple stress-related mechanisms can act as triggers that precipitate the occurrence of a cardiovascular or cerebrovascular event 97 (FIG. 3) .
The common pathology in acute cardiovascular events is rupture or disruption of the fibrous cap of the atherosclerotic plaque coupled with active inflammation and hypercoagulability, which are the result of multiple processes [98] [99] [100] . Relevant physiological changes, in addition to stress-induced ischaemia, include: an increase in the levels of pro-inflammatory cytokines and adhesion molecules that contribute to athero sclerotic plaque destabiliza tion and monocyte chemotaxis; release of tissue factor; increased blood viscosity; platelet activation and increases in the levels of coagulation and fibrinolytic factors and in the hepatic production of fibrinogen (an acute-phase protein important in both coagulation and whole blood viscosity); systemic vasoconstriction and an increase in arterial blood-pressure levels; increases in sinus node firing rates and atrioventricular conduction velocity, thereby increasing the heart rate; changes in the balance between sympathetic Nature Reviews | Cardiology and para sympathetic cardiac control in favour of the former; and increases in myocardial oxygen consumption and myocardial work 101 . These physiological responses interact with one another; for example, reduced parasympathetic activity correlates with systemic inflammation and catecholamine release promotes cardiac repolarization abnormalities, whereas heightened haemodynamic responses are associated with increased plasma viscosity [102] [103] [104] . These responses, in turn, stimulate pathophysiological effects, including electrical instability of the heart and transient myocardial ischaemia as well as plaque disruption and thrombus formation. Acute clinical events can occur, such as ventricular fibrillation, myocardial infarction, or stroke (FIG. 3) .
As shown in FIG. 4 , the findings from large-scale population studies are consistent with the above-described process and show that stress is linked to both increased systemic inflammation and coagulation and/or viscosity as indicated by high platelet levels 78 and excess risk of pulmonary embolism 29 . Stress is also related to cardiac arrhythmia 79 , elevated ambulatory blood pressure 105 a measure that is more sensitive to temporary elevations in blood pressure than clinic-assessed blood pressureand increased alcohol use in men 78, 82, 106 , three additional factors that can precipitate the rupture of vulnerable atherosclerotic plaque or the formation of blood clots.
Studies that used online diary (eDiary) assessments of emotions combined with portable devices that continuously monitor electrical activity of the heart confirmed that stress often precedes arrhythmia episodes 47, 107 . In atrial fibrillation -the most common form of clinical cardiac arrhythmia -the irregular rhythm can cause blood to pool in the left atrium and form clots that can travel to the brain and cause a stroke. An individualparticipant meta-analysis published in 2017 that included nearly 85,500 men and women showed that people who work long hours have an increased risk of developing atrial fibrillation 79 . This association was evident in individ uals with no history of coronary heart disease or stroke, suggesting that the adverse effects of this stressor on atrial fibrillation are not attributable to pre-existing cardiovascular disease. This finding is consistent with the hypothesis that stress-induced arrhythmias might in part mediate the association between stress and increased risk of stroke 10 .
Mechanisms of stress in the brain. Other advances in the study of stress mechanisms have focused on the central nervous system rather than peripheral physiological responses affecting the heart and vessels. Resting metabolic activity within the amygdala (a region of the brain implicated in emotional experience) was associated with the risk of developing cardiovascular disease in a 4-year follow-up study of 300 participants (median age 55 years): the higher the amygdala activity, the higher the risk of cardiovascular disease 108 . Amygdala hyperactivity was related to conventional stress mechanisms, such as arterial inflammation measured by arterial ¹⁸F-FDG uptake, in line with findings from experimental studies 109 . These observations are preliminary, but give rise to the hypothesis that the amygdala could be a critical structure in the central nervous system mechanisms linking stress to cardiovascular disease events. Additionally, the dorsal anterior cingulate cortex is particularly involved in the regulation of cardiovascular responses to acute challenge 110 , and inflammatory cytokine expression after reappraisal of emotional stimuli links this neural region with preclinical atherosclerosis 111 . Conversely, greater levels of social support, which might be cardioprotective, are associated with diminished activity in the dorsal anterior cingulate cortex 112 .
Reduced self-care. Finally, it has been suggested that stressed individuals with cardiovascular disease have poorer self-care, are more likely to ignore symptoms of disease, and have longer prehospital delays related to acute cardiovascular events than individuals who are free of stress 113 . Patients with heart failure and coro nary heart disease who become depressed show poor self-care and reduced adherence to medication 114, 115 . In addition, stress has been linked to reduced chances of successful modification of risk factors (such as smoking cessation) 116 and high stress can also adversely affect participation in rehabilitation among patients 62 . and increase the risk of multiple chronic conditions in adulthood. In a meta-analysis of >120,000 participants from eight studies, individuals with at least four adverse childhood experiences were at a higher risk of future cardiovascular disease than those with no such experience (OR 2.1, 95% CI 1.7-2.6) 58 . In these individuals, the risk ratios for adverse behavioural and mental health outcomes in adulthood, such as sexual risk taking, psychi atric disorders, drug use, and problematic alcohol use, were higher than the risk of cardiovascular disease, varying between 3 and 6 (REF. 58 ).
Stress in cardiovascular disease aetiology
In adult general populations, the observed associations between chronic stress and risk of cardiovascular disease have been weaker 8, 22, 117 (FIG. 1) . A meta-analysis of first cardiac events in the general population showed a 1.5-fold (95% CI 1.2-1.9) pooled relative risk related to social isolation or loneliness compared with other stressors across nine cohort studies 23 . The risk ratio for coronary heart disease was 1.4-fold (95% CI 1.1-1.8) for people experiencing multiple work stressors (high workload combined with low control over work, plus high efforts relative to income, job security, or recognition) compared with people with low work stress 9 . These associations remained robust after exclusion of the first 3 or 5 years of follow-up, suggesting that the associ ation is not attributable to bias arising from the effects of pre-existing cardiovascular disease on stress levels 9, 48 . Research on other presentations of cardiovascular disease includes studies on stroke and atrial fibrillation. A pooled analysis of unpublished and published data on >500,000 men and women found that individuals working long hours (≥55 h per week) had a 1.3 times (95% CI 1.1-1.6) higher risk of incident stroke than individuals working the standard 35-40 h per week 10 . A similar association between isolation or loneliness and stroke incidence was reported in another meta-analysis, with a relative risk of 1.3 (1.0-1.7) that was unchanged when studies that might have information bias were excluded 56 . Job strain was associated with a 1.2-fold (95% CI 1.1-1.5) increased risk of ischaemic stroke, but no association was found with haemorrhagic stroke 57 . In addition, individuals with long working hours and job strain were more likely to develop atrial fibrillation 79, 118, 119 .
Disease triggering
In investigating triggering, researchers have exploited natural experiment designs that include a change in stress level owing to an adverse life event. This design does not rely on randomization and is, therefore, subject to confounding and bias, but probably to a lesser extent than traditional prospective studies with a single baseline assessment and follow-up of the outcome.
Natural disasters, such as earthquakes and hurricanes, as well as unnatural events (for example, threat of imminent missile attack) have been associated with increases in cardiovascular events immediately after the disaster [120] [121] [122] [123] . Excess cardiovascular event rates have been observed even in major sporting competitions 124, 125 . In a German study, for example, the incidence of acute cardiac events was 2.0 times higher (95% CI 1.7-2.4) on match days involving the German national team during the 2006 FIFA World Cup than in the control period 63 (FIG. 1) .
Other triggers, such as the death of a close person, exceptionally stressful work changes, and emotional upset, have also been associated with considerable increases in the risk of both cardiovascular events and death 29, 32, 33, 60, [126] [127] [128] [129] (FIG. 1) . For example, a matched Summary of the meta-analyses and large-scale studies on the associations between adulthood stress and factors that increase the risk of rupture or disruption of the fibrous cap of the atherosclerotic plaque and subsequent thrombus formation, leading to cardiac or cerebrovascular events. The associations of adulthood stress with high work-time ambulatory blood pressure, increased risk of atrial fibrillation and pulmonary embolisms, high platelet and white cell counts, and increased alcohol consumption (indicated by elevated γ-glutamyl transferase (GGT) levels and self-reported increasing alcohol use) support the notion that stress contributes to the triggering of cardiac and cerebrovascular events. Strong associations are shown with red plots, moderate and weak associations with blue plots, and non-significant associations with white plots. AF, atrial fibrillation; BP, blood pressure; f, female; HR, hazard ratio; I, individual-participant data; m, male; MD, mean difference; OR, odds ratio; P, data from published studies; RR, relative risk; SD, standard deviation. Receiving a cancer diagnosis 1 cohort study using the UK primary-care database, which included >30,000 elderly people with experience of partner bereavement and >83,000 matched nonbereavement controls, showed that within a month of the partner's death the risk of cardiovascular disease in the bereaved compared with the non-bereaved group was 2.1-fold for myocardial infarction and 2.4-fold for stroke 29 . Moreover, the bereaved group had a 2.2-fold increased risk of acute coronary syndromes other than myocardial infarction and a 2.4-fold risk of pulmonary embolism in the first 90 days.
The large INTERHEART study 32 , conducted in 52 countries with a case-control design, found that anger or emotional upset in the case period immediately preceding symptom onset was associated with 2.4-times increased odds of acute myocardial infarction (99% CI 2.1-2.9), with no effect modification by geographical region, prior cardiovascular disease, cardiovascular risk factor burden, cardiovascular disease prevention medica tions, or time of day or day of onset of the infarction. Other studies have shown that the stress induced by receiving a diagnosis of cancer might have serious consequences. In a cohort study of >6 million adults, the relative risk of cardiovascular death after cancer diagnosis was 5.6 (95% CI 5.2-5.9) during the first week and 3.3 (95% CI 3.1-3.4) during the first 4 weeks 129 . An advanced approach, known as case-crossover design, is based on within-person comparisons between a hazard period before symptom onset and a control period in the same individual, thereby taking into account base-rate issues and individual differences between patients and controls 130 . A meta-analysis published in 2013 identified five studies that used a comparable time period of 24 h before the hazard period as a control 23 . In this analysis, the pooled relative risk of symptom onset for acute coronary syndrome in periods of stress, anger, or depressed mood was 2.5 (95% CI 1.7-3.5). Single studies have reported even larger effects. Mostofsky and others 60 , for example, found an incidence of acute cardiac event as high as 21-fold in the 24 h follow ing the death of a close person 60 . This finding is in agreement with a previous case-crossover study reporting an odds ratio of 14.0 (95% CI 4.4-89.7) for negative emotions in the 2 h before stroke onset 131 . When major stressful events in the month before ischaemic stroke are considered, the increased risk might be lower, at 3.0-fold (95% CI 2.2-4.0), but still substantial 132 . Major downsizing in workplaces that have traditionally provided stable employment, such as public-sector organizations in Finland before the major economic recession in the 1990s, is a potential stressor not only for those who lose their jobs, but also for employees who continue working in heavily downsized units with increasing workloads 133 . According to one analysis, Finnish public-sector employees remaining in their organizations after downsizing in the 1990s had a 2.0-fold (95% CI 1.0-3.9) higher risk of cardiovascular death than those who worked in places where no downsizing had occured 33 . Splitting the follow-up period into two halves produced a 5.1-fold (95% CI 1.4-19.3) increase in cardiovascular mortality following major downsizing during the first years, but no excess risk was observed during the second half of the follow-up 33 . Given the long preclinical phase in cardiovascular disease, this finding suggests that the affected employees were those who already had underlying disease.
Besides the above-reviewed common presentations of cardiovascular disease, stress has been linked to stress cardiomyopathy, a transient systolic and diastolic left ventricular dysfunction with wall-motion abnormalities often accompanied with emotional or physical stress [134] [135] [136] . Stress cardiomyopathy is considered an acute heart failure syndrome 136 , and one hypothesis is that an overstimulation of the sympathetic nervous system resulting in a cardiotoxic discharge of circulating catecholamines has a role in this acute coronary syndrome 135, 137 . Data from cohort studies and registries suggest that more than half of patients with stress cardio myopathy have a history of psychiatric or neurological disorders, supporting a neurogenic origin for this condition 136 .
Stress and disease progression
In aetiological research, the aim is to examine whether the development of a disease can be reliably attributed to a particular risk factor. However, both episodic and chronic stress can also affect the outcomes of the disease and its course and progression. This type of research is prognostic as the aim is to examine factors that affect the risk of future adverse outcomes in individuals who already have cardiovascular disease.
Arrhythmias, particularly ventricular tachy cardia and ventricular fibrillation, are common causes of sudden cardiac death. Implantable cardioverter-defibrillators are used in the management of ventricular arrhythmia and stored ECGs from these devices have been used to investi gate associations of stress with arrhythmia in patients with coronary heart disease. A casecrossover study showed that approximately 15% of atrial arrhythmias leading to discharge of the implantable cardioverter-defibrillator were preceded by neg ative emotion, compared with 3% in the control periods, a fivefold difference 47 . Another study of patients with implantable cardioverter-defibrillators showed that ventricu lar tachyarrhythmias increased significantly in the 30 days following the terrorist attacks of 11th September 2001 in the USA compared with the control months 138 . Work stress has been linked to an increased risk of recurrent cardiac events in patients with coronary heart disease, but the sample size in these studies has typically been small and the findings were not entirely consistent 27, [139] [140] [141] [142] [143] . A more holistic assessment of perceived life stress, irrespective of the source, has yielded clearer findings. A measure combining work, family, and life-event stress predicted increased 3-year mortality in the β-Blocker Heart Attack trial, and the effect was accentu ated when coupled with social isolation 144 . In a cohort study of 4,200 patients with acute myo cardial infarction published in 2012, participants who were stressed had an elevated 2-year risk of death compared with those who were not stressed, the mortality being 12.9% and 8.6%, respectively 62 . This association was not attributable to sociodemographic differences, clinical factors, revascularization status, or discharge risk as indicated by the confounder-adjusted hazard ratio of 1.4 (95% CI 1.2-1.8) for mortality under stress compared with no stress.
As summarized in FIG. 1 , to date, few studies have examined the association between stress and disease progression. Given the promising findings, this field would merit more high-quality research.
Prevention and treatment
Preventive recommendations need to be justified by strong evidence, because non-evidence-based interventions might expose the target population to potentially harmful or ineffective strategies, and the use of such interventions might also divert attention and resources from strategies that might be more effective 145 . The two major approaches to prevention are a universal (population-wide) strategy and a targeted strategy, the first involving the general population and the latter being focused on those at the highest risk of adverse end points 146 . The number-needed-to-treat (NNT) is a simple statistic to evaluate cost-effectiveness and is defined as the number of individuals who should be intervened to prevent one extra event. In TABLE 2, we provide the NNT to prevent one additional cardio vascular event for various interventions and risk factors to illustrate that the unit cost should be lower for population-wide interventions than for targeted interventions in order to achieve the same cost-effectiveness 48, [147] [148] [149] [150] [151] . Accordingly, in the general working population, 550 employees without coronary heart disease and with job strain should become free of job strain to prevent one myocardial infarction or cardiac death within 5 years 48 . The NNT in the general population for increase in physical activity to a level recommended by the WHO (>150 min per week of moderate-intensity physical activity) is 310 to prevent one myocardial infarction and 195 to prevent one major cardiovascular event within 5 years 148 . For statin and antihypertensive pharmacotherapy, the NNT to prevent one major cardio vascular event is 80 for a targeted group of individ uals at intermediate risk of cardiovascular disease 149 . The corresponding NNT for antihypertensive medication alone is 70 for people with hypertension 147 , and the NNT for statin treatment alone is 18 for patients with established cardiovascular disease 151 . The relevance of stress as a target for cardiovascular disease prevention, universal or targeted, remains under debate. At least four alternative scenarios exist for such prevention. First, stress considered as a universal risk factor: this strategy is the most far-reaching option, encouraging the entire population to reduce stress or its adverse effects. Second, stress treated as a risk factor in high-risk groups only: this option assumes the association between stress and cardiovascular disease is causal, but only targeted anti-stress interventions are clinically meaningful and cost-effective. Third, stress considered only a risk marker: under this scenario, stress is treated as a risk marker to identify at-risk groups for targeted prevention that focuses on the management of standard cardiovascular risk factors in this group. Fourth, wait for more definite evidence: this option is to defer the inclusion of stressors in universal or targeted cardiovascular disease prevention programmes until better evidence is forthcoming 152 .
Universal strategies
Data from randomized, general-population trials on stress and cardiovascular disease are limited; the few intervention studies available are small in scale and are based on case-specific, tailor-made solutions rather than scalable interventions 153, 154 . A major barrier for large intervention studies is the practical challenge of modifying stressors in healthy individuals, because methods of stress intervention are often time consuming and difficult to implement at the population level. Adherence is poor even for treatments as simple as taking a pill once a day to lower blood pressure or cholesterol levels. In stress management interventions, which might require study participants to modify long-held habits, the adherence problem is orders of magnitude greater. A further barrier is funding; large drug trials are expensive, but are also often profitable investments for the pharmaceutical industry. For stress intervention studies, however, the financial incentives for industrial partners are less clear. ACE, angiotensin-converting enzyme; CHD, coronary heart disease; CVD, cardiovascular disease. *Number needed to treat (NNT) to prevent one cardiovascular event within 5 years by eliminating job strain and physical inactivity in the general population; NNT was estimated from observational data by comparing risks between exposed and unexposed groups with 5 years of follow-up. ‡
NNT to prevent one cardiovascular event within 5 years by statin and antihypertensive drug treatment in targeted populations; NNT was estimated from the results from randomized, controlled trials for 5 years of follow-up.
Natural (nonrandomized) experiments might be informative. A far-reaching, population-wide option against stress in the general population is to legislate against common stressors in the same way as other health hazards are dealt with, for example, exposure to chemical toxins. This approach has been adopted at least in work stress. One example comes from the European Union and Canada, where legislation that provides workers with the right to cap their working hours at 48 h per average week has been implemented 155 . Another example is a French law for employees' "right to disconnect" (REF. 156 ). This law requires companies to establish hours when staff should not send or answer emails, with a view to ensuring rest periods and preventing burnout by protecting private time. Neither of these laws was enacted with cardio vascular disease prevention in mind. Nonetheless, analy ses of risk of cardiovascular disease before and after the implementation of the legislation, with comparisons to countries with no such policy, could provide an opportunity to evaluate the effects of stress-related interventions in the general population. We are not aware of the existence of such analyses.
Population-strategies for reducing the risk of acute triggering of cardiac events by stress might also be possible 157 . One possibility is increasing precautions in highrisk situations, such as major sporting events and natural disasters. Improved access to defibrillators, public health awareness programmes, and education of emergency and health professional staff in the dangers of these settings would ensure more rapid responses to potentially fatal symptoms. Mobile technologies and mHealth interventions might also offer ways of delivering mental health support to mitigate stress in people experiencing war, ethnic conflict, and human-caused and natural disasters. The platforms include social media, video teleconferencing, text messaging, and smartphone-based applications (for example, PTSD Coach has been downloaded >243,000 times in 96 countries) 158 . To date, systematic research on the potential benefits of these interventions for cardiovascular disease prevention is not available.
For stressors that are difficult to manipulate, a way forward is to intervene on the intermediary factors that are downstream on the causal pathway and target them by proven, evidence-based prevention strategies. As cardiovascular disease is a multifactorial condition, removal of any of the standard risk factors would reduce overall risk. Accordingly, physical activity has been suggested as an intervention to mitigate adverse stress effects 159 . Indirect evidence supports this approach, with meta-analyses of trial findings showing that physical activity might alleviate distress feelings, such as depression and anxiety 160 , and extensive observational evidence support a protective effect of physical activity on cardiovascular disease 148 . Workplace wellness programmes, such as those promoted by the AHA, are designed to support healthy lifestyles, including routine health screenings and the facilitation of healthy eating, weight management, and physical activity 161, 162 . These wellness programmes could also be beneficial for people under stress, although, again, systematic research on benefits and harms of these programmes is lacking. FIGURE 5 illustrates that, in terms of reducing absolute risk, prevention and treatment focusing on individuals at high overall risk of cardiovascular disease 32 and patients with pre-existing disease 62 might seem a more attractive target group than the general population 10 . The rationale is that, for example, a 1.5-fold increase in relative risk of disease owing to stress would mean that a person with a high (>10%) overall risk of a cardiovascular disease event in the next 10 years on the basis of established risk factors would actually have a 15% overall risk after also accounting for stress. By contrast, in a person with a low (1%) overall risk of cardiovascular disease, a 1.5-fold excess risk of disease owing to stress would increase the overall risk only to 1.5%, a relatively trivial clinical difference.
Targeted strategies
The greatest stress effects are the triggering of cardiovascular events among individuals with high cardiovascular risk or with established disease when exposed to stressful events, such as emotional upset, adverse changes at work, major life events, and natural and unnatural catastrophes. These stressors are difficult to address by interventions, because such events are typically stochastic and, therefore, are difficult to predict. For this reason, a more typical approach in targeted interventions involves strengthening stress management skills and psychosocial support more generally.
A systematic review and meta-analysis of psychological treatment among cardiac patients, published in 2007, identified 43 relevant randomized trials, of which 23 reported mortality data for almost 10,000 patients 163 . Figure 5 | Absolute risk difference between groups exposed and not exposed to stress. Estimated 5-year risk of incident disease or death by status of stress in stroke-free population 10 , coronary heart disease (CHD)-free population 48 , and high-risk population 32 , and in patients with a history of myocardial infarction (MI) 62 . The bars illustrate that given the low overall incidence rates, the difference in absolute disease risk between disease-free individuals with and without stress is small. By contrast, high-risk populations and patients with cardiovascular disease have high overall rates of morbidity and mortality, and in these groups, the moderately and strongly increased relative risk associated with stress translates to large differences in absolute risk between those exposed to stress versus those not exposed to stress. A benefit of the psychological treatment was observed among men in terms of reduced all-cause mortality at ≤2 years of follow-up. The odds ratio for all-cause mortality for the comparison between the group receiving psychological treatment and usual care with the group receiving only usual care was 0.7 (95% CI 0.6-1.0) for men, but 1.0 (95% CI 0.9-1.7) for women. A longer follow-up attenuated this effect. Although some individ ual trials have shown impressive results for the use of psycho logical treatment for the prevention of cardio vascular disease 164, 165 , summary evidence from a Cochrane review, published in 2017, of 35 studies including a total of 10,703 patients with coronary heart disease showed little benefit at the population level 166 . The review suggests that psychological treatment might reduce cardiac mortality, but the trials available had low quality and no robust data suggesting an effect of psychological treatment on total mortality, the risk of revascularization procedures, or the rate of nonfatal myocardial infarction.
Comprehensive cardiac rehabilitation for patients with cardiovascular disease often includes a psychological component related to lifestyle behaviour change, risk factor modification, and psychosocial well-being 167 . Although exercise training remains the cornerstone of cardiac rehabilitation, an additional goal is to offer stress management interventions for those in need 168 . Metaanalyses suggest that exercise-based cardiac rehabilitation is effective for reducing the risk of cardiovascular disease 167, 169 , although notable exceptions have null findings (for example, the large UK RAMIT trial 170 ). Exercise training in patients with chronic disease might additionally have stress-mitigating effects 171 . No specific cardiovascular benefits have been shown for including stress management as part of rehabilitation 167, 169 .
Current clinical guidelines
Although findings from randomized, controlled trials are the gold standard evidence, such evidence is lacking for much of modern medical practice, and in many cases, no randomized, controlled trial is even being planned to provide evidence for action 172 . An argument that has been used to justify this practice is that waiting for more data is an implicit decision not to act or to act on the basis of past practice rather than best available evidence 172 . The 2016 European clinical guidelines for the prevention of cardiovascular disease include family history of premature cardiovascular disease, familial hyperlipidaemia, smoking, high blood pressure, diabetes, and raised blood lipid levels as main risk factors 173 . Stress is acknowledged as a potential contributing factor to both development and progression of the disease, and a targeted rather than universal strategy for stress management is recommended.
More specifically, the guideline ranks the strength of evi dence and recommendations into four classes. Class I evidence (evidence and/or general agreement that a given treatment or procedure is beneficial, useful, and effective and "is recommended") relates to risk factors such as hypertension and high serum cholesterol levels. The evidence on the status of stress as a cardiovascular disease risk factor is rated as class IIa, indicating that the weight of evidence is in favour of usefulness and/or efficacy and that addressing the risk factor "should be considered" (REF. 173 ). The guideline recommends assessment and management of stress and other psychosocial factors (socioeconomic adversity, lack of social support, stress at work and in family life, hostility, depression, anxiety, and other mental disorders) in individuals at high risk of cardiovascular disease or with established cardiovascular disease, but not in the general population.
The Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the ESC additionally emphasizes that "the success of cardiac rehabilitation may critically depend on the interdependence of the body and mind and this interaction needs to be reflected through the assessment and management of psychosocial risk factors in line with robust scientific evidence, by trained staff, integrated within the core cardiac rehabilitation team" (p. 1290) 168 .
Other prevention guidelines provide either indirect recommendations in terms of stress prevention or state that insufficient evidence is available to provide a recommendation. The Canadian 2016 guidelines, for example, note that health-care providers can explore stress management techniques for patients with myocardial infarction and depression to optimize quality of life; the importance of moderate sleep duration is also emphasized 174 . By contrast, the most recent WHO report on cardiovascular disease management in primary health care, the AHA and ACC risk assessment tool, and the AHA/American Stroke Association secondary prevention guideline do not list stress as a specific prevention target [175] [176] [177] . Nonetheless, most clinical guidelines make recommendations on the composition of a multidisciplinary cardiac rehabilitation team and acknowledge that core components should include initial assessment, structured exercise training, nutrition counselling, patient education, risk factor management, and psychosocial support 178 .
Conclusions
Meta-analyses published during the past 5-10 years suggest that stress in adulthood has a modest role in cardiovascular disease aetiology among healthy individuals compared with severe childhood stress or adult classic risk factors, such as hypertension, high serum cholesterol levels, diabetes, smoking, and obesity. By contrast, adulthood stress might be an important disease trigger in susceptible persons and a determinant of prognosis and outcome in those with pre-existing cardiovascular or cere brovascular disease. Knowledge on the cardiovascular implications of stress pathophysiology, including disturbance in autonomic, metabolic, inflammatory, and haemostatic processes, is accumulating and new discover ies involved the identification of functional changes in the central nervous system. Although the main emphasis in stress studies has traditionally been on cardiovascular disease aetiology, the emerging evidence is increasingly shifting weight into the role of stress in disease progression in individuals at high risk or with cardiovascular or cerebrovascular disease.
To complement research on disease causation and mechanisms, studies aimed at developing cost-effective, scalable stress interventions that can deliver substantial health gains are needed; in other words, science of delivery. The first steps towards clinical application have already been made in the European guidelines by acknowledging stress as a contributing factor to cardiovascular disease. Precision medicine is an emerging approach in the medical sciences that seeks to predict more accurately which prevention and treatment strat egies for a disease will work in a specific group of individuals 179 . In the future, it is important to examine whether information on stress can contribute to precision medicine approaches by characterizing distinct groups of individuals in need of special attention or as part of targeted prevention and treatment strategies.
Although clinical guidelines have favoured, if anything, targeted rather than universal strategies for stress prevention, this approach might need reconsideration when more evidence accumulates. Population-wide policies and strategies have been shown to be cost-effective in reducing classic risk factors, for example, smoking by means of clean indoor air legislation, cigarette price increases, and reductions in licences for tobacco outlets [180] [181] [182] . Modelling studies suggest that universal diet interventions, such as the UK sugar tax, might also benefit public health 183 . Given the much higher numbers of people with stress in the general population than among individuals with advanced disease, the populationattributable risk (a measure of preventive potential) is broadly similar for heart disease in these groups at 3-7% for chronic stressors in the general population and approximately 4% for stress triggers in high-risk individuals 9, 48, 62, 126 . These rates suggest there might be scope for multiple stress intervention strategies, including targeted interventions for people with high overall risk of cardio vascular disease and a general plan for the general population; that is, a public health approach.
